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COVID-19 is a new highly contagious viral infection that can be transmitted by asymptomatic patients. 
Without a vaccine or a specific cure for this disease, our current management strategy is to attempt 
to contain its spread. The many risks and challenges of managing COVID-19 in prisons have been 
reported and include: overcrowded prison environments, the poor general heath profile of prisoners, 
the quality of prison healthcare services, existing high levels of communicable diseases, and the 
inability to comply with most social distancing and hand hygiene rules.1 However, little attention 
has been focused on the opportunities that prison healthcare can provide in the management of 
COVID-19 and other public health concerns.
Opportunities for improved prison health care
The majority of the prison population globally (estimated at 11 million people) are young adult males, 
a cohort not typically considered vulnerable to the serious effects of COVID-19.2 Prison life is based on 
structure and routine, factors which may contribute to effective management of infection outbreaks.
Screening and prevention
Over 30 million people worldwide come into prisons’ health services annually.2 Prison committal is an 
opportunity to review prisoners’ health needs, and has been identified as an opportunity to screen 
for infections.3 A previous systematic review highlighted the success of opt- out committal HIV and 
hepatitis C screening in prison settings.3
Prison committal provides an opportunity to screen patients for COVID-19, and should be part 
of any containment strategy involving increased testing and contact tracing. People entering and 
exiting prison are some of the most vulnerable and underserved by community health services. They 
experience stigma and discrimination, creating barriers to accessing health care, and incarceration 
could be an opportunity to address unmet health needs.4,5 These may include screening and treatment 
for mental health problems, communicable diseases, and substance use disorders.4 Incarceration also 
provides a window for health promotion, self- care, improving health literacy, and disease prevention.5 
Prisons are also locations where large numbers of people can be offered vaccinations, and this will 
hopefully form a critical part of the long- term strategy for the management of COVID-19.
Delivery of prison health care
Many prisoners have complex medical and psychosocial needs that are rarely addressed fully 
while incarcerated.4,5 There have been many reports of new approaches and rapid adaptation of 
telemedicine to manage the risks of COVID-19 transmission in community settings.6,7 General practice 
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has been at the forefront of these changes, and GPs are the main providers of routine health care in 
prisons globally.5,7 There have been no reports in the published literature of such innovation in the 
delivery of health care in prisons. While acknowledging the challenges of adopting telemedicine in 
prison settings, it would seem like an appropriate and efficient way to deliver health care to large 
groups of prisoners. It also could have the added benefit of giving prisoners access to the opinions 
of medical specialists in secondary care, while reducing the requirement to attend hospital services 
including accident and emergency departments. This would reduce cost, free up staff, and reduce the 
risks of spreading COVID- 19 both in prison and community settings.
Drug use and policy
Early release of certain groups of prisoners to reduce prison populations worldwide has been 
recommended by the World Health Organization (WHO) and other international organisations in recent 
months.1 For years, public health specialists and experts on international drug policy have called for 
the implementation of less punitive and more human rights- and harm reduction- based drug policies 
to reduce the incarceration of drug users.8 The concentration of communicable infections in prisons 
is mainly due the incarceration of people who inject drugs (PWID).4 PWID acquire HIV and hepatitis 
C virus in the community and in prison settings, and lack of access to evidence- based harm reduction 
measures — such as opioid agonist treatment (OAT), and needle and syringe programmes — is a 
major concern, particularly in prison settings.9,10 There is now an opportunity to revisit this deficit and 
use the present focus on COVID-19 management to advocate for increased harm reduction services 
and the decriminalisation of drug users as measures to reduce present and future communicable 
infections.
Challenges to improved prison health care
There is great variation in prison healthcare standards globally.4 Systematic neglect and underfunding 
of these services in many countries has resulted in prison health services that lack ambition, oversight, 
and links to public health.4,5
Transitioning back to the community
Reducing prison populations is a critical aspect of the management of COVID-19 in prisons. However, 
it must be recognised that the period immediate after release is considered high risk and is associated 
with high levels of deaths from overdose.10,11 Maintaining prisoners on OAT as they transition back 
to the community is protective, but it needs planning and organisation. Many prisoners experience 
homelessness, and releasing them back into the community will increase their risk of acquiring 
COVID-19. Community drug users will experience the same risks as the general population, and will 
have enhanced risks due to their own vulnerability and through drug use itself.12 Older drug users 
and those with underlying health conditions have even more complex vulnerabilities.12 It is important 
that any decisions made to release prisoners involves a risk assessment, and release is planned and 
supported to ensure that it does not increase their risk of contracting COVID-19.12
Public health and human rights
There have been numerous calls for increased involvement of public health specialists in prison health 
care, and it is recognised that improving the health of prisons will ultimately improve the health of the 
wider community.4,5 Prisons are dynamic institutions with the daily movement of prisoners, staff, and 
visitors between prison and the community. They are a place of work for many, including healthcare 
providers. Most prisoners return to their communities.
Prisoners should enjoy the same standards of health care that are available in the community, and 
their rights should be safeguarded according to international treaties.8 Prison and state authorities 
should not use the management of COVID-19 and potential restrictions to undermine the rights of 
prisoners, and any COVID-19 related initiatives have to be underpinned by these accepted principles. 
The WHO are leading the global public health response to COVID-19. Their recommendations are 
being implemented in large numbers of countries worldwide. A unified and structured public health 
approach is crucial to achieving influence in advising on national health policy. This is a once in a 
generation opportunity to embed prison health into public health, and it should not be missed
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Conclusion
The current pandemic provides an unprecedented opportunity to review the purpose of incarceration, 
historically seen as punishment and rehabilitation. Our treatment of people while in custody should be 
safe, secure, and humane. Social inequalities are a major driver of prison populations. Improving social 
and health inequalities could improve the lives of so many into the future. As we adjust to and manage 
the economic impact of COVID-19, we must strive for a safer and humane custody, underpinned by a 
human rights agenda and a realisation of the duty of care that society has to those deprived of their 
liberty.
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